The Currently Incurable Scientist: The Future of anti-EGFR Therapy?
For readers interested in “the science” of current & potential future CRC treatments – my latest monthly column of The Currently Incurable Scientist has been published on the Fight Colorectal Cancer website. This month’s installment is called “The Future of anti-EGFR Therapy?”
Similar to last month’s column, it is a 2-parter. The first part describes how current anti-EGFR therapies work in the treatment of CRC. The second part discusses two example clinical trials testing next generation anti-EGFR therapeutic strategies for CRC. Long time readers will recognize that both subjects were partially (but not totally) discussed in a different format here last Spring!
This was an interesting topic in particular for me to write about since I am currently undergoing anti-EGFR therapy myself! A truly complete melding of my roles as a patient-scientist-advocate. As a patient I take the anti-EGFR therapeutic antibody Erbitux. As a scientist, I can explain its anti-cancer activity. As an advocate, I utilize the Fight Colorectal Cancer advocacy platform to educate fellow patients how it works & potential future treatment options.
Are you dizzy yet? I think I am. But I hope you enjoy the column anyways. 😉